These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23884024)

  • 1. Bradykinin and its role in osteoarthritis.
    De Falco L; Fioravanti A; Galeazzi M; Tenti S
    Reumatismo; 2013 Jul; 65(3):97-104. PubMed ID: 23884024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Role of Bradykinin in the Pathogenesis of Osteoarthritis and its Possible Clinical Implications.
    Tenti S; Pascarelli NA; Cheleschi S; Guidelli GM; Fioravanti A
    Curr Rheumatol Rev; 2016; 12(3):177-184. PubMed ID: 27030254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knee osteoarthritis: a role for bradykinin?
    Meini S; Maggi CA
    Inflamm Res; 2008 Aug; 57(8):351-61. PubMed ID: 18787773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists.
    Wiernas TK; Griffin BW; Sharif NA
    Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bradykinin and the effect of the bradykinin receptor antagonist icatibant in porcine sepsis.
    Barratt-Due A; Johansen HT; Sokolov A; Thorgersen EB; Hellerud BC; Reubsaet JL; Seip KF; Tønnessen TI; Lindstad JK; Pharo A; Castellheim A; Mollnes TE; Nielsen EW
    Shock; 2011 Nov; 36(5):517-23. PubMed ID: 21921836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats.
    Cialdai C; Giuliani S; Valenti C; Tramontana M; Maggi CA
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1025-32. PubMed ID: 19745108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons.
    Yasuyoshi H; Kashii S; Zhang S; Nishida A; Yamauchi T; Honda Y; Asano Y; Sato S; Akaike A
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2273-8. PubMed ID: 10892873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of peptide and nonpeptide antagonists of bradykinin B2 receptors on the venoconstrictor action of bradykinin.
    Marceau F; Levesque L; Drapeau G; Rioux F; Salvino JM; Wolfe HR; Seoane PR; Sawutz DG
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1136-43. PubMed ID: 8014858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
    Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
    Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
    Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammation.
    Félétou M; Lonchampt M; Robineau P; Jamonneau I; Thurieau C; Fauchère JL; Villa P; Ghezzi P; Prost JF; Canet E
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1078-84. PubMed ID: 7791078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of RNA synthesis by bradykinin involves both the B1 and B2 receptor subtypes.
    Yau L; Pinsk M; Zahradka P
    Arch Biochem Biophys; 1996 Apr; 328(1):115-21. PubMed ID: 8638919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies of a bradykinin B1/B2 antagonist linked to a human neutrophil elastase inhibitor; a heterodimer for the treatment of inflammatory disorders.
    Leimer AH; Kroona HB; Blodgett JK; Whalley ET; Ross SE; Burkard MR; Zuzack JS; Gernert DL; Dyckes DF
    Can J Physiol Pharmacol; 1997 Jun; 75(6):633-8. PubMed ID: 9276141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
    Krause K; Metz M; Zuberbier T; Maurer M; Magerl M
    J Dtsch Dermatol Ges; 2010 Apr; 8(4):272-4. PubMed ID: 19758369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin and inflammatory pain.
    Dray A; Perkins M
    Trends Neurosci; 1993 Mar; 16(3):99-104. PubMed ID: 7681240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for bradykinin in the therapeutic and side effects of angiotensin-converting enzyme inhibitors?
    Marceau F
    Can J Cardiol; 1997 Feb; 13(2):187-94. PubMed ID: 9070170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence?
    Hochberg M; Chevalier X; Henrotin Y; Hunter DJ; Uebelhart D
    Curr Med Res Opin; 2013 Mar; 29(3):259-67. PubMed ID: 23186102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.